Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · Real-Time Price · USD

Compare

0.8422

-0.0211 (-2.44%)

At close: Feb 10, 2026, 4:00 PM EST

0.8216

-0.0206 (-2.45%)

Pre-market: Feb 11, 2026, 4:57 AM EST

Oncolytics Biotech Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	12.35	15.94	34.91	11.67	41.26	31.22
Short-Term Investments	-	-	-	20.47	-	-
Cash & Short-Term Investments	12.35	15.94	34.91	32.14	41.26	31.22
Cash Growth	-36.97%	-54.34%	8.63%	-22.11%	32.17%	120.66%
Other Receivables	0.05	0.07	0.02	0.03	0.08	0.09
Receivables	0.05	0.07	0.02	0.03	0.08	0.09
Prepaid Expenses	1.65	1.89	3.25	1.7	2.78	2.43
Other Current Assets	-	0.98	-	1.82	0.78	-
Total Current Assets	14.05	18.88	38.17	35.68	44.9	33.74
Property, Plant & Equipment	1.01	1.31	0.65	0.65	0.98	0.61
Other Long-Term Assets	-	-	-	1	-	-
Total Assets	15.06	20.19	38.82	37.33	45.88	34.35
Accounts Payable	4.2	1.09	1.08	2.25	0.59	1.81
Accrued Expenses	2.98	3.71	2.49	1.4	1.39	-
Current Portion of Leases	0.28	0.28	0.13	0.22	0.29	0.25
Other Current Liabilities	0.2	1.62	0.53	0.08	0.41	0.66
Total Current Liabilities	7.66	6.69	4.24	3.95	2.69	2.71
Long-Term Leases	0.56	0.79	0.29	0.16	0.36	0.15
Long-Term Unearned Revenue	6.73	6.73	6.73	6.73	6.73	6.73
Total Liabilities	14.94	14.2	11.26	10.83	9.78	9.59
Common Stock	458.63	438.19	430.91	404.04	391.35	356.82
Additional Paid-In Capital	45.66	44.54	42.12	40.05	34.16	31.02
Retained Earnings	-504.97	-477.71	-446	-418.25	-393.42	-367.11
Comprehensive Income & Other	0.79	0.96	0.54	0.66	4.01	4.02
Shareholders' Equity	0.12	5.98	27.56	26.5	36.1	24.75
Total Liabilities & Equity	15.06	20.19	38.82	37.33	45.88	34.35
Total Debt	0.84	1.06	0.42	0.37	0.66	0.4
Net Cash (Debt)	11.52	14.88	34.49	31.77	40.61	30.82
Net Cash Growth	-37.86%	-56.86%	8.58%	-21.77%	31.77%	125.91%
Net Cash Per Share	0.13	0.19	0.51	0.55	0.76	0.76
Filing Date Shares Outstanding	106.15	86.42	75.42	62.83	57.11	52.08
Total Common Shares Outstanding	103.64	80.02	74.42	61.33	55.04	46.17
Working Capital	6.4	12.19	33.94	31.74	42.21	31.03
Book Value Per Share	0.00	0.07	0.37	0.43	0.66	0.54
Tangible Book Value	0.12	5.98	27.56	26.5	36.1	24.75
Tangible Book Value Per Share	0.00	0.07	0.37	0.43	0.66	0.54
Machinery	-	0.86	0.75	0.74	0.69	0.78
Leasehold Improvements	-	0.18	0.23	0.23	0.23	0.5

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q